Cvs Health (CVS) Net Income towards Common Stockholders (2009 - 2026)

Cvs Health has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $3.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 65.94% year-over-year to $3.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.9 billion (down 44.64% YoY), and the FY2025 full-year result was $1.7 billion, down 62.32% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $3.0 billion, up from $2.9 billion in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $3.0 billion in Q2 2022, with the low at -$4.0 billion in Q3 2025.
• Historically, Net Income towards Common Stockholders has averaged $1.3 billion across 5 years, with a median of $1.9 billion in 2023.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 166.64% — and 2025, when it plunged 5719.72%.
• Cvs Health's Net Income towards Common Stockholders stood at $2.3 billion in 2022, then dropped by 12.22% to $2.0 billion in 2023, then fell by 20.71% to $1.6 billion in 2024, then jumped by 80.1% to $2.9 billion in 2025, then gained by 1.16% to $3.0 billion in 2026.
• The last three Net Income towards Common Stockholders figures came in at $3.0 billion (Q1 2026), $2.9 billion (Q4 2025), and -$4.0 billion (Q3 2025), per Business Quant data.